Ventyx Biosciences
IPOEncinitas, United States · $165.0M raised
- Headquarters
- Encinitas, California
- Business Model
- B2B
- Website
- ventyxbio.com
- Total Funding
- $165.0M
- Last Round
- $51.0M Series BSep 2021
- Rounds
- 2
About
Clinical-stage biopharmaceutical company developing innovative oral therapies for patients with autoimmune, inflammatory, and CNS diseases; acquired by Eli Lilly.
Summary
Ventyx Biosciences is a Biotech company based in Encinitas, United States. It has raised $165.0M in total across 2 rounds, most recently a $51.0M Series B round in Sep 2021. Investors include Surveyor Capital, venBIO Partners and Third Point Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...